PL173783B1 - Sposób wytwarzania nowych pochodnych N-(2,4-lub 2,5-dwupodstawionych tetrahydrofuryloalkilo)-N-(fenyloetyl-beta-olo)aminy - Google Patents

Sposób wytwarzania nowych pochodnych N-(2,4-lub 2,5-dwupodstawionych tetrahydrofuryloalkilo)-N-(fenyloetyl-beta-olo)aminy

Info

Publication number
PL173783B1
PL173783B1 PL93299693A PL29969393A PL173783B1 PL 173783 B1 PL173783 B1 PL 173783B1 PL 93299693 A PL93299693 A PL 93299693A PL 29969393 A PL29969393 A PL 29969393A PL 173783 B1 PL173783 B1 PL 173783B1
Authority
PL
Poland
Prior art keywords
formula
compound
cis
trans
compounds
Prior art date
Application number
PL93299693A
Other languages
English (en)
Polish (pl)
Other versions
PL299693A1 (en
Inventor
Serge Auvin
Pierre Braquet
Colette Broquet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL299693A1 publication Critical patent/PL299693A1/xx
Publication of PL173783B1 publication Critical patent/PL173783B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL93299693A 1992-07-17 1993-07-15 Sposób wytwarzania nowych pochodnych N-(2,4-lub 2,5-dwupodstawionych tetrahydrofuryloalkilo)-N-(fenyloetyl-beta-olo)aminy PL173783B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215274A GB9215274D0 (en) 1992-07-17 1992-07-17 Derivatives of(phenylethyl-beta-ol)amine

Publications (2)

Publication Number Publication Date
PL299693A1 PL299693A1 (en) 1994-03-21
PL173783B1 true PL173783B1 (pl) 1998-04-30

Family

ID=10718914

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93299693A PL173783B1 (pl) 1992-07-17 1993-07-15 Sposób wytwarzania nowych pochodnych N-(2,4-lub 2,5-dwupodstawionych tetrahydrofuryloalkilo)-N-(fenyloetyl-beta-olo)aminy

Country Status (32)

Country Link
US (1) US5447942A (en, 2012)
JP (1) JP3204811B2 (en, 2012)
AT (1) AT403693B (en, 2012)
AU (1) AU672791B2 (en, 2012)
BE (1) BE1006429A3 (en, 2012)
CA (1) CA2100381C (en, 2012)
CH (1) CH687705A5 (en, 2012)
DE (1) DE4323976C2 (en, 2012)
DK (1) DK84793A (en, 2012)
DZ (1) DZ1704A1 (en, 2012)
ES (1) ES2067417B1 (en, 2012)
FI (1) FI933235A7 (en, 2012)
FR (2) FR2693723B1 (en, 2012)
GB (2) GB9215274D0 (en, 2012)
GR (1) GR1001565B (en, 2012)
HK (1) HK52596A (en, 2012)
HU (1) HUT64757A (en, 2012)
IE (1) IE73266B1 (en, 2012)
IN (1) IN183086B (en, 2012)
LU (1) LU88383A1 (en, 2012)
MA (1) MA22937A1 (en, 2012)
MY (1) MY109395A (en, 2012)
NL (1) NL9301241A (en, 2012)
NO (1) NO302946B1 (en, 2012)
NZ (1) NZ248041A (en, 2012)
OA (1) OA09838A (en, 2012)
PL (1) PL173783B1 (en, 2012)
PT (1) PT101308B (en, 2012)
RU (1) RU2060252C1 (en, 2012)
SE (1) SE503805C2 (en, 2012)
TN (1) TNSN93081A1 (en, 2012)
ZA (1) ZA934667B (en, 2012)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1771435A4 (en) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst MODULATORS OF NEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM
WO2020148325A1 (en) 2019-01-15 2020-07-23 Phenex-Fxr Gmbh Neutral lxr modulators
GB202304652D0 (en) * 2023-03-29 2023-05-10 Atrogi Ab New compounds and medical uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700692A (en) 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
ES8702880A1 (es) * 1984-04-17 1987-01-16 Glaxo Group Ltd Un procedimiento para la produccion de compuestos de fenetanolamina.
DE3731198A1 (de) * 1987-02-07 1988-08-18 Bayer Ag 2-aminomethyltetrahydrofurane
US4937268A (en) * 1987-03-12 1990-06-26 Glaxo Group Limited Chemical compounds
GB2230525A (en) * 1989-04-14 1990-10-24 Glaxo Group Ltd 1-(Hydroxyphenyl)-2-aminoethanol derivatives
GB2230775A (en) * 1989-04-24 1990-10-31 Glaxo Group Ltd Phenethanolamine compounds
AU629989B2 (en) * 1989-10-10 1992-10-15 Glaxo Group Limited Phenethanolamine derivatives

Also Published As

Publication number Publication date
IE73266B1 (en) 1997-05-21
JP3204811B2 (ja) 2001-09-04
DK84793D0 (da) 1993-07-16
FR2693723B1 (fr) 1994-10-28
CA2100381A1 (en) 1994-01-18
MA22937A1 (fr) 1994-04-01
GB9314718D0 (en) 1993-08-25
ES2067417B1 (es) 1995-11-16
PT101308A (pt) 1994-05-31
FI933235A0 (fi) 1993-07-16
AU672791B2 (en) 1996-10-17
OA09838A (fr) 1994-08-15
DK84793A (da) 1994-01-18
GB9215274D0 (en) 1992-09-02
AU4204293A (en) 1994-01-20
BE1006429A3 (fr) 1994-08-23
PL299693A1 (en) 1994-03-21
GR1001565B (el) 1994-05-31
FR2693653B1 (fr) 1994-10-28
DE4323976C2 (de) 2003-05-28
FR2693723A1 (fr) 1994-01-21
SE9302437L (sv) 1994-01-18
HUT64757A (en) 1994-02-28
GB2268742A (en) 1994-01-19
TNSN93081A1 (fr) 1994-03-17
NO932383D0 (no) 1993-06-29
NO932383L (no) 1994-01-18
FI933235L (fi) 1994-01-18
NO302946B1 (no) 1998-05-11
IE930472A1 (en) 1994-01-26
PT101308B (pt) 1999-10-29
RU2060252C1 (ru) 1996-05-20
GB2268742B (en) 1995-11-08
ATA142793A (de) 1997-09-15
JPH06157492A (ja) 1994-06-03
IN183086B (en, 2012) 1999-09-04
CH687705A5 (fr) 1997-01-31
FR2693653A1 (fr) 1994-01-21
FI933235A7 (fi) 1994-01-18
SE503805C2 (sv) 1996-09-09
DZ1704A1 (fr) 2002-02-17
HU9302057D0 (en) 1993-10-28
US5447942A (en) 1995-09-05
DE4323976A1 (de) 1994-01-20
AT403693B (de) 1998-04-27
NZ248041A (en) 1994-06-27
SE9302437D0 (sv) 1993-07-16
ZA934667B (en) 1994-01-25
HK52596A (en) 1996-04-03
ES2067417A1 (es) 1995-03-16
CA2100381C (en) 2004-09-21
NL9301241A (nl) 1994-02-16
LU88383A1 (fr) 1994-04-01
MY109395A (en) 1997-01-31

Similar Documents

Publication Publication Date Title
Nonomura et al. The Complete Structure of Maitotoxin, Part II: Configuration of the C135 C142 Side Chain and Absolute Configuration of the Entire Molecule
DE69333771T2 (de) Pyran-2-onen und 5,6-dihydropyran-2-onen brauchbar für die Behandlung von Hyperplasie und andere Krankheiten
EP2314580B1 (de) Verfahren zur Herstellung von synthetischen Cannabinoiden
JPH05221961A (ja) ビタミンｄ化合物、該化合物の製造方法およびその中間体
DE69513367T2 (de) Vitamin d3 derivat und verfahren zu dessen herstellung
Kitamura et al. Synthesis of maytansinoid. A general approach via heteroconjugate addition strategy and the total synthesis of (.+-.)-maysine and (.+-.)-N-methylmaysenine
CA1238331A (fr) Ethers dont les restes organiques comportent des atomes chiraux, leur preparation et leur application au dedoublement d'alcools ou de certains composes hemiacetaliques
PL173783B1 (pl) Sposób wytwarzania nowych pochodnych N-(2,4-lub 2,5-dwupodstawionych tetrahydrofuryloalkilo)-N-(fenyloetyl-beta-olo)aminy
Bravo et al. Asymmetric synthesis and structural analysis of 5-O-benzoyl-2, 3-dideoxy-3-fluoro-. alpha.,. beta.-D-ribofuranose and-xylofuranose from homochiral 1-fluoro-3-sulfinylacetone
DE3856074T2 (de) Optisch aktive Allylalkohol und Verfahren zur Herstellung von Leucotrien-B4, das sie verwendet
Thijs et al. Rubrenolide, total synthesis and revision of its reported stereochemical structure
EP0296564B1 (en) Method for preparing dodecahydro-3a,6,6,9a-tetramethylnaphtho[2,1-b] furan and novel haloethyl decalin derivatives
DE69308965T2 (de) Verfahren zum Herstellen einer gesättigten monocyclischen Kohlenwasserstoffverbindung und ein Zwischenprodukt für dieses
EP0994868B1 (de) Verfahren zur herstellung von optisch aktivem 5-methyl-2- (1-methyl-butyl)-5-propyl-1,3-dioxan
HU183288B (en) Process for preparing new 4-/1-hydroxy-1-methyl-ethyl/-3-cyclohexen-1-one-ketals
JP3497528B2 (ja) ペルヒドロ−５，５，８ａ−トリメチル−２−ナフタレノンの製法及び該製法のための出発化合物
WO2005007638A1 (ja) 光学活性ハロヒドリン誘導体およびそれを用いた光学活性エポキシアルコ－ル誘導体の製造法
JPH09316017A (ja) エーテル化合物の製造法
JP2002513732A (ja) バンレイシ科のアセトゲニン用中間体
Bagli et al. Prostaglandin VIII—Synthesis of some 9-oxoprostynoic acids
JP2016515112A (ja) 合成方法
Tanaka A Michael Addition and Alkylation Sequence Using Methyl 2-(Trimethylsilyl)-propenoate. Stereoselective Synthesis of a-Silyl Esters
JPH06263667A (ja) 光学活性６―（４―置換インデン―１―イル）―２―メチル―３―ヘプタノール類の製造法
JPH03176449A (ja) 光学活性２―メチレンペンタナール誘導体
Maluleka A Novel Synthesis of Cyclic and Acyclic 3-Alkenoic Acids via Ionization/Elimination of β-Lactones